According to this latest study, the 2021 growth of Artesunate Drugs will have significant change from previous year. By the most conservative estimates of global Artesunate Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Artesunate Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Artesunate Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Monoaromatic Artesunate
Compound Artesunate
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artesunate Drugs Market Size 2016-2026
2.1.2 Artesunate Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Artesunate Drugs Segment by Type
2.2.1 Monoaromatic Artesunate
2.2.2 Monoaromatic Artesunate
2.3 Artesunate Drugs Market Size by Type
2.3.1 Global Artesunate Drugs Market Size CAGR by Type
2.3.2 Global Artesunate Drugs Market Size Market Share by Type (2016-2021)
2.4 Artesunate Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artesunate Drugs Market Size by Application
2.5.1 Global Artesunate Drugs Market Size CAGR by Application
2.5.2 Global Artesunate Drugs Market Size Market Share by Application (2016-2021)
3 Artesunate Drugs Market Size by Players
3.1 Artesunate Drugs Market Size Market Share by Players
3.1.1 Global Artesunate Drugs Revenue by Players (2019-2021E)
3.1.2 Global Artesunate Drugs Revenue Market Share by Players (2019-2021E)
3.2 Global Artesunate Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artesunate Drugs by Regions
4.1 Artesunate Drugs Market Size by Regions (2016-2021)
4.2 Americas Artesunate Drugs Market Size Growth (2016-2021)
4.3 APAC Artesunate Drugs Market Size Growth (2016-2021)
4.4 Europe Artesunate Drugs Market Size Growth (2016-2021)
4.5 Middle East & Africa Artesunate Drugs Market Size Growth (2016-2021)
5 Americas
5.1 Americas Artesunate Drugs Market Size by Country (2016-2021)
5.2 Americas Artesunate Drugs Market Size by Type (2016-2021)
5.3 Americas Artesunate Drugs Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artesunate Drugs Market Size by Region (2016-2021)
6.2 APAC Artesunate Drugs Market Size by Type (2016-2021)
6.3 APAC Artesunate Drugs Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artesunate Drugs by Country (2016-2021)
7.2 Europe Artesunate Drugs Market Size by Type (2016-2021)
7.3 Europe Artesunate Drugs Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artesunate Drugs by Region (2016-2021)
8.2 Middle East & Africa Artesunate Drugs Market Size by Type (2016-2021)
8.3 Middle East & Africa Artesunate Drugs Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Artesunate Drugs Market Forecast
10.1 Global Artesunate Drugs Forecast by Regions (2021-2026)
10.1.1 Global Artesunate Drugs Forecast by Regions (2021-2026)
10.1.2 Americas Artesunate Drugs Forecast
10.1.3 APAC Artesunate Drugs Forecast
10.1.4 Europe Artesunate Drugs Forecast
10.1.5 Middle East & Africa Artesunate Drugs Forecast
10.2 Americas Artesunate Drugs Forecast by Countries (2021-2026)
10.2.1 United States Artesunate Drugs Market Forecast
10.2.2 Canada Artesunate Drugs Market Forecast
10.2.3 Mexico Artesunate Drugs Market Forecast
10.2.4 Brazil Artesunate Drugs Market Forecast
10.3 APAC Artesunate Drugs Forecast by Region (2021-2026)
10.3.1 China Artesunate Drugs Market Forecast
10.3.2 Japan Artesunate Drugs Market Forecast
10.3.3 Korea Artesunate Drugs Market Forecast
10.3.4 Southeast Asia Artesunate Drugs Market Forecast
10.3.5 India Artesunate Drugs Market Forecast
10.3.6 Australia Artesunate Drugs Market Forecast
10.4 Europe Artesunate Drugs Forecast by Country (2021-2026)
10.4.1 Germany Artesunate Drugs Market Forecast
10.4.2 France Artesunate Drugs Market Forecast
10.4.3 UK Artesunate Drugs Market Forecast
10.4.4 Italy Artesunate Drugs Market Forecast
10.4.5 Russia Artesunate Drugs Market Forecast
10.5 Middle East & Africa Artesunate Drugs Forecast by Region (2021-2026)
10.5.1 Egypt Artesunate Drugs Market Forecast
10.5.2 South Africa Artesunate Drugs Market Forecast
10.5.3 Israel Artesunate Drugs Market Forecast
10.5.4 Turkey Artesunate Drugs Market Forecast
10.5.5 GCC Countries Artesunate Drugs Market Forecast
10.6 Global Artesunate Drugs Forecast by Type (2021-2026)
10.8 Global Artesunate Drugs Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Information
11.1.2 Fosun Pharma (Guilin) Artesunate Drugs Product Offered
11.1.3 Fosun Pharma (Guilin) Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Fosun Pharma (Guilin) Main Business Overview
11.1.5 Fosun Pharma (Guilin) Latest Developments
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Information
11.2.2 Ipca Laboratories Artesunate Drugs Product Offered
11.2.3 Ipca Laboratories Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Ipca Laboratories Main Business Overview
11.2.5 Ipca Laboratories Latest Developments
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Information
11.3.2 Sanofi Aventis Artesunate Drugs Product Offered
11.3.3 Sanofi Aventis Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Sanofi Aventis Main Business Overview
11.3.5 Sanofi Aventis Latest Developments
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Information
11.4.2 Ajanta Pharma Artesunate Drugs Product Offered
11.4.3 Ajanta Pharma Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Ajanta Pharma Main Business Overview
11.4.5 Ajanta Pharma Latest Developments
11.5 Shin Poong
11.5.1 Shin Poong Company Information
11.5.2 Shin Poong Artesunate Drugs Product Offered
11.5.3 Shin Poong Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Shin Poong Main Business Overview
11.5.5 Shin Poong Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Artesunate Drugs Product Offered
11.6.3 Cipla Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Acino
11.7.1 Acino Company Information
11.7.2 Acino Artesunate Drugs Product Offered
11.7.3 Acino Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Acino Main Business Overview
11.7.5 Acino Latest Developments
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Information
11.8.2 MCW Healthcare Artesunate Drugs Product Offered
11.8.3 MCW Healthcare Artesunate Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 MCW Healthcare Main Business Overview
11.8.5 MCW Healthcare Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Artesunate Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Monoaromatic Artesunate
Table 3. Major Players of Compound Artesunate
Table 4. Artesunate Drugs Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Artesunate Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Artesunate Drugs Market Size Market Share by Type (2016-2021)
Table 7. Artesunate Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Artesunate Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Artesunate Drugs Market Size Market Share by Application (2016-2021)
Table 10. Global Artesunate Drugs Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Artesunate Drugs Revenue Market Share by Players (2019-2021E)
Table 12. Artesunate Drugs Key Players Head office and Products Offered
Table 13. Artesunate Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Artesunate Drugs Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Artesunate Drugs Market Size Market Share by Regions 2016-2021
Table 18. Americas Artesunate Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Artesunate Drugs Market Size Market Share by Country (2016-2021)
Table 20. Americas Artesunate Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Artesunate Drugs Market Size Market Share by Type (2016-2021)
Table 22. Americas Artesunate Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Artesunate Drugs Market Size Market Share by Application (2016-2021)
Table 24. APAC Artesunate Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Artesunate Drugs Market Size Market Share by Region (2016-2021)
Table 26. APAC Artesunate Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Artesunate Drugs Market Size Market Share by Type (2016-2021)
Table 28. APAC Artesunate Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Artesunate Drugs Market Size Market Share by Application (2016-2021)
Table 30. Europe Artesunate Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Artesunate Drugs Market Size Market Share by Country (2016-2021)
Table 32. Europe Artesunate Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Artesunate Drugs Market Size Market Share by Type (2016-2021)
Table 34. Europe Artesunate Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Artesunate Drugs Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Artesunate Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Artesunate Drugs Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Artesunate Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Artesunate Drugs Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Artesunate Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Artesunate Drugs Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Artesunate Drugs
Table 43. Key Application and Potential Industries of Artesunate Drugs
Table 44. Key Challenges of Artesunate Drugs
Table 45. Key Trends of Artesunate Drugs
Table 46. Global Artesunate Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Artesunate Drugs Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Artesunate Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Artesunate Drugs Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Artesunate Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Artesunate Drugs Market Size Market Share Forecast by Application (2021-2026)
Table 52. Fosun Pharma (Guilin) Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 53. Fosun Pharma (Guilin) Artesunate Drugs Product Offered
Table 54. Fosun Pharma (Guilin) Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Fosun Pharma (Guilin) Main Business
Table 56. Fosun Pharma (Guilin) Latest Developments
Table 57. Ipca Laboratories Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 58. Ipca Laboratories Artesunate Drugs Product Offered
Table 59. Ipca Laboratories Main Business
Table 60. Ipca Laboratories Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Ipca Laboratories Latest Developments
Table 62. Sanofi Aventis Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 63. Sanofi Aventis Artesunate Drugs Product Offered
Table 64. Sanofi Aventis Main Business
Table 65. Sanofi Aventis Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Sanofi Aventis Latest Developments
Table 67. Ajanta Pharma Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 68. Ajanta Pharma Artesunate Drugs Product Offered
Table 69. Ajanta Pharma Main Business
Table 70. Ajanta Pharma Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Ajanta Pharma Latest Developments
Table 72. Shin Poong Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 73. Shin Poong Artesunate Drugs Product Offered
Table 74. Shin Poong Main Business
Table 75. Shin Poong Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Shin Poong Latest Developments
Table 77. Cipla Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 78. Cipla Artesunate Drugs Product Offered
Table 79. Cipla Main Business
Table 80. Cipla Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Cipla Latest Developments
Table 82. Acino Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 83. Acino Artesunate Drugs Product Offered
Table 84. Acino Main Business
Table 85. Acino Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Acino Latest Developments
Table 87. MCW Healthcare Details, Company Type, Artesunate Drugs Area Served and Its Competitors
Table 88. MCW Healthcare Artesunate Drugs Product Offered
Table 89. MCW Healthcare Main Business
Table 90. MCW Healthcare Artesunate Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. MCW Healthcare Latest Developments
List of Figures
Figure 1. Artesunate Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artesunate Drugs Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Artesunate Drugs Market Size Market Share by Type in 2020
Figure 7. Artesunate Drugs in Hospital
Figure 8. Global Artesunate Drugs Market: Hospital (2016-2021) & ($ Millions)
Figure 9. Artesunate Drugs in Clinic
Figure 10. Global Artesunate Drugs Market: Clinic (2016-2021) & ($ Millions)
Figure 11. Artesunate Drugs in Other
Figure 12. Global Artesunate Drugs Market: Other (2016-2021) & ($ Millions)
Figure 13. Global Artesunate Drugs Market Size Market Share by Application in 2020
Figure 14. Global Artesunate Drugs Revenue Market Share by Player in 2020
Figure 15. Global Artesunate Drugs Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Artesunate Drugs Market Size 2016-2021 ($ Millions)
Figure 17. APAC Artesunate Drugs Market Size 2016-2021 ($ Millions)
Figure 18. Europe Artesunate Drugs Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Artesunate Drugs Market Size 2016-2021 ($ Millions)
Figure 20. Americas Artesunate Drugs Market Size Market Share by Country in 2020
Figure 21. Americas Artesunate Drugs Market Size Market Share by Type in 2020
Figure 22. Americas Artesunate Drugs Market Size Market Share by Application in 2020
Figure 23. United States Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Artesunate Drugs Market Size Market Share by Regions in 2020
Figure 27. APAC Artesunate Drugs Market Size Market Share by Type in 2020
Figure 28. APAC Artesunate Drugs Market Size Market Share by Application in 2020
Figure 29. China Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Artesunate Drugs Market Size Market Share by Country in 2020
Figure 36. Europe Artesunate Drugs Market Size Market Share by Type in 2020
Figure 37. Europe Artesunate Drugs Market Size Market Share by Application in 2020
Figure 38. Germany Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Artesunate Drugs Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Artesunate Drugs Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Artesunate Drugs Market Size Market Share by Application in 2020
Figure 46. Egypt Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Artesunate Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 52. APAC Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 53. Europe Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 55. United States Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 56. Canada Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 59. China Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 60. Japan Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 61. Korea Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 63. India Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 64. Australia Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 65. Germany Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 66. France Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 67. UK Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 68. Italy Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 69. Russia Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 70. Spain Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 73. Israel Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Artesunate Drugs Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Artesunate Drugs Market Size 2021-2026 ($ Millions)